Roche-backed study finds Tamiflu saved lives in flu pandemic
Published on Mar 19, 2014 9:28 AM
LONDON (REUTERS) - Using Roche's medicine Tamiflu saved lives during the H1N1 swine flu pandemic four years ago, according to a new scientific study published on Wednesday.
The pooled analysis of data, involving more than 29,000 patients from 38 countries, was funded by the Swiss drugmaker which hopes the findings will reassure governments about the value of its flu drug following criticism from some doctors.
Jonathan Nguyen-Van-Tam of the University of Nottingham and colleagues found that treatment with neuraminidase inhibitor drugs - principally Tamiflu - reduced the risk of death during the pandemic by 19 percent compared with no treatment.
The greatest benefit was seen when treatment was started within two days of symptoms developing, when the risk of death was halved, they reported in the journal Lancet Respiratory Medicine.
To continue reading, log in if you are a subscriber
If you are not a subscriber, you can get instant, unlimited access here